Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66
- PMID: 25975357
- DOI: 10.1185/03007995.2015.1035241
Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66
Comment in
-
Re: Pareek A, Chandurkar N, Thomas N, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin 2014;30:1257-66.Curr Med Res Opin. 2015 Jun;31(6):1087-92. doi: 10.1185/03007995.2015.1035242. Curr Med Res Opin. 2015. PMID: 26020537 No abstract available.
Comment on
-
Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone.Curr Med Res Opin. 2014 Jul;30(7):1257-66. doi: 10.1185/03007995.2014.909393. Epub 2014 May 2. Curr Med Res Opin. 2014. PMID: 24669876 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical